Related Experiment Video
Updated: Jul 19, 2026

13:51
The MultiBac Protein Complex Production Platform at the EMBL
Published on: July 11, 2013
An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression
Liang Shan1, Leyao Wang, Juan Yin
1Department of Microbiology and Microbial Engineering, School of Life Sciences, Fudan University, Shanghai 200433, China.
The Journal of Gene Medicine
|October 20, 2006
Summary
This study improved baculovirus gene delivery by incorporating Epstein-Barr virus elements, enabling prolonged transgene expression in mammalian cells. The enhanced baculovirus vector shows promise for gene therapy applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Virology
Background:
- Autographa californica multiple nucleopolyhedrovirus (AcMNPV) is a potential gene delivery vector for mammalian cells.
- Limitations include transient expression and low transduction efficiency due to lack of replication in mammalian cells.
Purpose of the Study:
- To enhance baculovirus gene delivery by enabling sustained transgene expression in mammalian cells.
- To investigate the role of Epstein-Barr virus (EBV) elements (OriP and EBNA-1) in baculovirus vector maintenance and transgene expression.
Main Methods:
- Constructed recombinant baculovirus vectors with EBV's OriP and EBNA-1 genetic elements.
- Tested vector persistence and transgene (enhanced green fluorescence protein - EGFP) expression in mammalian cell lines (HEK293, Vero, Cos-7, Hone-1).
Main Results:
- Recombinant baculovirus with OriP and EBNA-1 demonstrated persistence in mammalian cells without selective pressure.
- Sustained EGFP expression for up to 60 days in HEK293 cells with enhanced expression levels.
- Baculovirus genome persistence correlated with EBNA-1 protein expression.
Conclusions:
- The improved baculovirus vector facilitates prolonged and enhanced foreign gene expression in mammalian cells.
- Sufficient EBNA-1 protein levels are crucial for maintaining the OriP-containing baculovirus genome.
- This novel vector holds potential for gene therapy applications.

